Table A4.
Time | Treatment OD600nm ± SD (n = 3) | |||||||
---|---|---|---|---|---|---|---|---|
Control | CBO (0.08%) | Meropenem (16 µg/mL) | CBO (0.08%) + Meropenem (16 µg/mL) | |||||
Without 0.1% SDS | With 0.1% SDS | Without 0.1% SDS | With 0.1% SDS | Without 0.1% SDS | With 0.1% SDS | Without 0.1% SDS | With 0.1% SDS | |
0 | 0.68 ± 0.027 | 0.68 ± 0.006 | 0.50 ± 0.016 | 0.49 ± 0.010 | 0.72 ± 0.025 | 0.66 ± 0.016 | 0.50 ± 0.017 | 0.45 ± 0.017 |
5 | 0.72 ± 0.047 | 0.70 ± 0.002 | 0.51 ± 0.007 | 0.46 ± 0.003 | 0.75 ± 0.005 | 0.66 ± 0.011 | 0.53 ± 0.008 | 0.43 ± 0.004 |
10 | 0.90 ± 0.007 | 0.76 ± 0.008 | 0.62 ± 0.015 | 0.50 ± 0.006 | 0.89 ± 0.013 | 0.72 ± 0.006 | 0.52 ± 0.007 | 0.42 ± 0.021 |
30 | 1.32 ± 0.005 | 1.05 ± 0.007 | 1.04 ± 0.004 | 0.67 ± 0.008 | 1.25 ± 0.021 | 1.02 ± 0.021 | 0.51 ± 0.015 | 0.40 ± 0.014 |
60 | 1.66 ± 0.007 | 1.37 ± 0.009 | 1.37 ± 0.004 | 0.92 ± 0.004 | 1.56 ± 0.031 | 1.34 ± 0.011 | 0.53 ± 0.015 | 0.38 ± 0.009 |